Financial Results attached
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sunshield Chemicals reported strong Q2 FY26 results with revenue from operations rising about 32% year-on-year to ₹12,240 lakhs (vs ₹9,291 lakhs in Q2 FY25), and about 38% growth for the half-year at ₹23,628 lakhs (vs ₹17,087 lakhs). Profit after tax jumped to ₹723 lakhs in Q2 (vs ₹319 lakhs, up ~127% YoY) and to ₹1,405 lakhs for H1 (vs ₹720 lakhs, up ~95% YoY), lifting EPS to ₹9.83 for the quarter and ₹19.11 for the half-year. Operating cash flow was healthy at ₹3,170 lakhs for H1 FY26, more than 70% higher than the year-ago period. Statutory auditor CNK & Associates LLP issued an unmodified (clean) limited review report. The company also completed its Rights Issue during the period, allotting 14,41,776 equity shares at ₹901 each (raising roughly ₹130 crores) on October 27, 2025.
Strong double-digit revenue and profit growth, improving margins, positive operating cash flow, and a clean audit opinion are positive signals for shareholders; however, the recent ₹130-crore rights issue will lead to share dilution, which investors should weigh against the growth outlook.